Influence of clinical communication on patients' decision making on participation in clinical trials (Q37253723)

19 August 2017

Influence of clinical communication on patients' decision making on participation in clinical trials (English)

1 reference

19 August 2017

0 references

1 reference

9

John C Ruckdeschel

0 references

Susan Eggly

object named as

Susan S Eggly

2

0 references

Felicity W K Harper

4

object named as

Felicity W K Harper

1 reference

19 August 2017

Terrance L Albrecht

1

1 reference

19 August 2017

Marci E J Gleason

3

1 reference

19 August 2017

Tanina S Foster

5

1 reference

19 August 2017

Amy M Peterson

6

1 reference

19 August 2017

Heather Orom

7

1 reference

19 August 2017

Louis A Penner

8

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

Journal of Clinical Oncology

19 August 2017

1 reference

19 August 2017

26

1 reference

19 August 2017

16

1 reference

19 August 2017

2666-2673

1 reference

Oncologists' recommendations of clinical trial participation to patients

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Provider roles in the recruitment of underrepresented populations to cancer clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

The physician-patient working alliance.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Factors influencing inclusion of patients with malignancies in clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

A portable, unobtrusive device for videorecording clinical interactions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Communication and informed consent

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Patient-physician communication concerning participation in cancer chemotherapy trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Communication and consumer decision making about cancer clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-Grade Abnormal smears).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Information seeking during "bad news" oncology interactions: Question asking by patients and their companions

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Processes to activate phase III clinical trials in a cooperative oncology group: the elephant is monstrous.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Patients' decision-making process regarding participation in phase I oncology research.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Predictors of enrollment in lung cancer clinical trials

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Communicating with realism and hope: incurable cancer patients' views on the disclosure of prognosis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Managing accrual in cooperative group clinical trials.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Seeking informed consent to cancer clinical trials: describing current practice.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Understanding patient decisions about clinical trials and the associated communication process: a preliminary report

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

Clinicians' attitudes to clinical trials of cancer therapy.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807688

How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials

3 September 2018

1 reference

12 December 2020

Participation in cancer clinical trials: race-, sex-, and age-based disparities

1 reference

12 December 2020

Why Cancer Patients Enter Randomized Clinical Trials: Exploring the Factors That Influence Their Decision

1 reference

12 December 2020

Information and decision-making preferences of hospitalized adult cancer patients

1 reference

12 December 2020

Strategic physician communication and oncology clinical trials

1 reference

12 December 2020

Participation in the RACS sentinel node biopsy versus axillary clearance trial

1 reference

12 December 2020

Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001

1 reference

12 December 2020

Altruism as a reason for participation in clinical trials was independently associated with adherence

1 reference

12 December 2020

Physician Perspectives on Cancer Clinical Trials and Barriers to Minority Recruitment

1 reference

12 December 2020

Factors associated with participation in breast cancer treatment clinical trials

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2007.14.8114

1 reference

19 August 2017

1 reference

19 August 2017

1 reference